A Fixed Dose Study of 323U66 SR in the Treatment of Major Depressive Disorder (MDD)

Clinical trial NCT01138007 · COMPLETED

Trial details

NCT number: NCT01138007
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Depressive Disorder, Major

Start date: 2010-06-17
Primary completion: 2012-08-01
Enrollment: 572

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.